Franklin Resources’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-386,415
Closed -$267K 2055
2020
Q4
$267K Buy
386,415
+8,317
+2% +$17.7K ﹤0.01% 1665
2020
Q3
$851K Sell
378,098
-54,412
-13% -$155K ﹤0.01% 1410
2020
Q2
$1.32M Sell
432,510
-61,706
-12% -$223K ﹤0.01% 1226
2020
Q1
$1.88M Sell
494,216
-5,368,512
-92% -$17.7M ﹤0.01% 1103
2019
Q4
$17.6M Buy
+5,862,728
New +$15.2M 0.01% 790

Other funds holding BMY.RT

Franklin Resources's BMY.RT Position: Q1 2021 in Review

Franklin Resources sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 386,415 shares — an estimated $267K sold.

Franklin Resources first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $17.6M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Franklin Resources reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Franklin Resources sold 386,415 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $267K.
  • Franklin Resources first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Franklin Resources's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $17.6M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Franklin Resources's 13F filing for Q1 2021, filed 13 May 2021.